BioVaxys Technology Corp.
BVAXF · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $212 | $1 | $142 | $593 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $436 | $88 | $0 | $0 |
| Inventory | $0 | -$88 | $0 | $0 |
| Other Curr. Assets | $653 | $113 | $361 | $148 |
| Total Curr. Assets | $1,301 | $113 | $715 | $874 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $7,397 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $151 | $232 |
| Total NC Assets | $0 | $0 | $151 | $7,629 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,301 | $113 | $866 | $8,504 |
| Liabilities | – | – | – | – |
| Payables | $1,557 | $2,656 | $1,313 | $216 |
| Short-Term Debt | $68 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,596 | $830 | $326 | $110 |
| Total Curr. Liab. | $3,221 | $3,486 | $1,639 | $327 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,221 | $3,486 | $1,639 | $327 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $27,044 | $21,993 | $17,052 | $14,758 |
| Retained Earnings | -$31,250 | -$27,296 | -$19,608 | -$8,022 |
| AOCI | $2,263 | $1,931 | $1,783 | $1,441 |
| Other Equity | $23 | -$0 | $0 | $0 |
| Total Equity | -$1,920 | -$3,372 | -$774 | $8,177 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,301 | $113 | $866 | $8,504 |
| Net Debt | -$144 | -$1 | -$142 | -$593 |